☆ 4.7 Editorial Material

CA 125 and the Detection of Recurrent Ovarian Cancer

CANCER (2010)

期刊

CANCER

卷 116, 期 12, 页码 2850-2853

出版社

JOHN WILEY & SONS INC

DOI: 10.1002/cncr.25203

关键词

-

类别

Oncology

资金

NCI NIH HHS [P50 CA083639, P50 CA083639-06A1, P30 CA016672-33, P30 CA016672, 5P50 CA83639] Funding Source: Medline

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Biochemical Research Methods

VCAM-1 complements CA-125 in detecting recurrent ovarian cancer

Jin Song, Lori J. J. Sokoll, Zhen Zhang, Daniel W. W. Chan

Summary: Close to 75% of ovarian cancer cases are diagnosed at an advanced stage, with a high rate of relapse after primary therapy. Therefore, it is crucial to identify strategies for early detection of ovarian cancer recurrence to improve outcomes.

CLINICAL PROTEOMICS (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

Ibrutinib Could Suppress CA-125 in Ovarian Cancer: A Hypothesis

Julian Matthias Metzler, Daniel Fink, Patrick Imesch

Summary: Ibrutinib, a small-molecule inhibitor of Bruton's tyrosine kinase, is used to treat hematological diseases like chronic lymphocytic leukemia. The hypothesis that it may suppress the tumor marker CA-125 in ovarian cancer is based on an observation in a patient with low-grade serous ovarian cancer who received ibrutinib for CLL. A mechanistic model explaining this potential drug effect is proposed for further research.

APPLIED SCIENCES-BASEL (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Electrochemical immunosensing by carbon ink/carbon dot/ZnO-labeled-Ag@polypyrrole composite biomarker for CA-125 ovarian cancer detection

Nattinee Krathumkhet, Toyoko Imae, Fu-ming Wang, Chiou-Chung Yuan, Jusni Manidae Lumban Gaol, Nophawan Paradee

Summary: In this study, a novel cancer antigen 125 (CA125) biomarker detection method based on electro-chemical immunosensor was demonstrated. The biomarker on conductive composite materials of carbon ink/carbon dot/zinc oxide (C-ink/CD/ZnO) was used as an electrode platform, enhancing the interaction of antibodies (Ab) with the catalytic performance of ZnO. The created immunosensor showed a wide linear range and low detection limit, making it an accurate and efficient diagnostic tool for CA125 and other biomarkers in clinical sample analysis.

BIOELECTROCHEMISTRY (2023)

添加到收藏夹

Article Oncology

Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment

Er Yue, Guangchao Yang, Yuanfei Yao, Guangyu Wang, Atish Mohanty, Fang Fan, Ling Zhao, Yanqiao Zhang, Tamara Mirzapoiazova, Tonya C. Walser, Lorna Rodriguez-Rodriguez, Yuman Fong, Ravi Salgia, Edward Wenge Wang

Summary: Ovarian cancer is a deadly disease with urgent need for new treatments. The development of a conditionally replicative oncolytic adenovirus (CRAd) that targets MUC16/CA-125 in cancer cells shows promising anti-cancer effects. This approach represents a unique and practical direction for further investigation in ovarian cancer treatment.

CANCERS (2021)

添加到收藏夹

Article Immunology

In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer

Lingeng Lu, Wenxue Ma, Caroline H. Johnson, Sajid A. Khan, Melinda L. Irwin, Lajos Pusztai

Summary: Somatic mutation-derived neoantigens are used to develop an mRNA vaccine targeting CA-125 neoantigen for breast and ovarian cancer. Immuno-bioinformatics tools were used to predict CD8' T cell epitopes and a self-adjuvant mRNA vaccine was constructed to enhance cross-presentation by dendritic cells. Immune responses post-immunization were estimated using an in silico algorithm, showing IFN-c and CD8' T cell response. The strategy described in this study can be used to design precision multi-epitope mRNA vaccines targeting multiple neoantigens.

VACCINE (2023)

添加到收藏夹

Article Oncology

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis

Christoph Wohlmuth, Vladimir Djedovic, Susanne K. Kjaer, Allan Jensen, Rosalind Glasspool, Patricia Roxburgh, Anna DeFazio, Sharon E. Johnatty, Penelope M. Webb, Francesmary Modugno, Diether Lambrechts, Joellen M. Schildkraut, Andrew Berchuck, Liv Cecilie Vestrheim Thomsen, Line Bjorge, Estrid Hogdall, Claus K. Hogdall, Ellen L. Goode, Stacey J. Winham, Keitaro Matsuo, Beth Y. Karlan, Jenny Lester, Marc T. Goodman, Pamela J. Thompson, Tanja Pejovic, Marjorie J. Riggan, Katherine Lajkosz, Alicia Tone, Taymaa May

Summary: This study analyzed data from 176 women with low-grade serous ovarian cancer through a multi-center collaborative effort, revealing that elevated post-treatment CA-125 levels are significantly associated with poor survival, while FIGO staging and residual disease also impact patient outcomes.

CANCERS (2022)

添加到收藏夹

Review Oncology

Prognostic Value of Elevated Pre-treatment Serum CA-125 in Epithelial Ovarian Cancer: A Meta-Analysis

Qingyi Wang, Xiaoling Feng, Xiaofang Liu, Siyu Zhu

Summary: According to the meta-analysis, higher pretreatment serum CA-125 levels are associated with poor prognosis in epithelial ovarian cancer (EOC) patients.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

The Role of Interleukin 6 (IL6), Cancer Antigen-125 (CA-125), and Human Epididymis Protein 4 (HE4) to predict tumor resectability in the advanced epithelial ovarian cancer patients

Syamel Muhammad, Reyhan Julio Azwan, Rauza Sukma Rita, Restu Susanti, Yusrawati

Summary: This study investigates the predictive role of IL6, CA-125, and HE4 in tumor resectability in pre-operative patients with advanced epithelial ovarian cancer and finds a correlation between these markers and tumor resectability.

PLOS ONE (2023)

添加到收藏夹

Article Chemistry, Analytical

A novel electrochemical sensor for monitoring ovarian cancer tumor protein CA 125 on benzothiophene derivative based electrodes

Omer Faruk Er, Hilal Kivrak, Omruye Ozok, Sebahattin Celik, Arif Kivrak

Summary: The COVID-19 crisis has a serious impact on ovarian cancer patients, highlighting the importance of early detection. In this study, a PTTC-based sensor was designed to detect CA-125, a common marker for ovarian cancer, with higher precision and speed using electrochemical methods. The PTTC-based GCE electrode showed promising sensitivity and reliability for CA-125 detection, with optimum conditions determined as 3 μL PTTC loading, 5000 ng/mL CA125 antigen concentration, and 30 min incubation time. The linear range of this electrode was found to be 1-100 ng/mL, with a limit of detection of 0.0096 ng/mL and a limit of quantification of 0.0288 ng/mL. These findings suggest that PTTC is a novel and promising material for the detection of ovarian cancer antigen CA-125.

JOURNAL OF ELECTROANALYTICAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Multidisciplinary

Nanoscale SPR sensor for the ultrasensitive detection of the ovarian cancer marker carbohydrate antigen 125

Sinem Diken Gur, Monireh Bakhshpour, Adil Denizli

Summary: In this study, a nanoscale surface plasmon resonance (SPR) sensor was developed to determine the level of ovarian cancer marker CA 125 in serum using the molecular imprinting method. The developed sensor system exhibited high sensitivity, selectivity, and reliability, and was able to accurately detect CA 125 levels even in complex media.

NEW JOURNAL OF CHEMISTRY (2022)

添加到收藏夹

Review Chemistry, Analytical

Application of Various Optical and Electrochemical Nanobiosensors for Detecting Cancer Antigen 125 (CA-125): A Review

Mehrab Pourmadadi, Ali Moammeri, Amin Shamsabadipour, Yasamin Farahanian Moghaddam, Abbas Rahdar, Sadanand Pandey

Summary: Diagnosing early-stage cancers is crucial for saving lives and reducing mortality rates. Detection of the cancer antigen CA-125 is a key step in the treatment of certain cancers, such as ovarian cancer. This review discusses various optical and electrochemical methods for detecting CA-125, compares their performance and sensitivity, investigates commercial detection kits, and evaluates their applicability and accuracy.

BIOSENSORS-BASEL (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Nadir CA-125 has prognostic value for recurrence, but not for survival in patients with ovarian cancer

Szymon Piatek, Grzegorz Panek, Zbigniew Lewandowski, Dominika Piatek, Przemyslaw Kosinski, Mariusz Bidzinski

Summary: The nadir CA-125 level in patients with epithelial ovarian cancer is associated with progression-free survival but not overall survival. Patients with nadir CA-125 levels between 11-35 U/ml after first-line treatment have a higher risk of recurrence compared to patients with levels <= 10 U/ml.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Oncology

The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary studyThe clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary study

John K. Chan, Chunqiao Tian, Joshua P. Kesterson, Michael T. Richardson, Ken Lin, Krishnansu S. Tewari, Thomas Herzog, Daniel S. Kapp, Bradley J. Monk, Yovanni Casablanca, Parviz Hanjani, Robert M. Wenham, Joan Walker, Leah McNally, Larry J. Copeland, Sharon Robertson, Samuel Lentz, Nick M. Spirtos, Jeffery G. Bell

Summary: This study aims to investigate the clinical and prognostic significance of CA-125 trends during chemotherapy in high-risk early-stage epithelial ovarian cancer patients. The results showed that normalization of CA-125 after the first cycle of chemotherapy was associated with better survival.

GYNECOLOGIC ONCOLOGY (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Role of biomarkers CA-125, CA-15.3 and CA-19.9 in the distinction between endometriomas and ovarian neoplasms

Jessica de Souza Magalhaes, Millena Prata Jammal, Paula Carolina Arvelos Crispim, Eddie Fernando Candido Murta, Rosekeila Simoes Nomelini

Summary: The study found that CA-19.9 is useful in distinguishing between endometriomas and ovarian cancers, with a higher diagnostic value in endometriomas. Furthermore, the combination analysis of CA-125 and CA-19.9 can aid in differentiating endometriomas from other ovarian lesions.

BIOMARKERS (2021)

添加到收藏夹

Article Oncology

Tubo-ovarian mass with raised CA-125 in a 21-year-old female

Roli Purwar, Kishan Soni, Ragini Tilak, Ashish Verma, Manoj Pandey

Summary: Peritonitis associated with Curvularia lunata is rare, with only five cases reported in the literature, all in middle-aged patients with comorbidities undergoing dialysis. This case report presents a 21-year-old female patient who was diagnosed with ovarian malignancy based on raised CA 125 and suspected tubo-ovarian mass on MRI, but was later found to have a pelvic collection with Curvularia lunata infection.

WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Proteome Profiling Uncovers an Autoimmune Response Signature That Reflects Ovarian Cancer Pathogenesis

Makoto Kobayashi, Hiroyuki Katayama, Ehsan Irajizad, Jody V. Vykoukal, Johannes F. Fahrmann, Deepali L. Kundnani, Chuan-Yih Yu, Yining Cai, Fu Chung Hsiao, Wei-Lei Yang, Zhen Lu, Joseph Celestino, James P. Long, Kim-Ann Do, Karen H. Lu, Jon J. Ladd, Nicole Urban, Robert C. Bast, Samir M. Hanash

CANCERS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS binders

Yao-Cheng Li, Nikki K. Lytle, Seth T. Gammon, Luke Wang, Tikvah K. Hayes, Margie N. Sutton, Robert C. Bast, Channing J. Der, David Piwnica-Worms, Frank McCormick, Geoffrey M. Wahl

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Oncology

Elimination of dormant, autophagic ovarian cancer cells and xenografts through enhanced sensitivity to anaplastic lymphoma kinase inhibition

Alicia M. Blessing, Janice M. Santiago-O'Farrill, Weiqun Mao, Lan Pang, Jing Ning, Daewoo Pak, Lakshmi Reddy Bollu, Philip Rask, LaKesla Iles, Hailing Yang, Samantha Tran, Ezzeddine Elmir, Geoffrey Bartholomeusz, Robert Langley, Zhen Lu, Robert C. Bast

CANCER (2020)

添加到收藏夹

Article Genetics & Heredity

In vivo modeling of metastatic human high-grade serous ovarian cancer in mice

Olga Kim, Eun Young Park, David L. Klinkebiel, Svetlana D. Pack, Yong-Hyun Shin, Zied Abdullaev, Robert E. Emerson, Donna M. Coffey, Sun Young Kwon, Chad J. Creighton, Sanghoon Kwon, Edmund C. Chang, Theodore Chiang, Alexander N. Yatsenko, Jeremy Chien, Dong-Joo Cheon, Yang Yang-Hartwich, Harikrishna Nakshatri, Kenneth P. Nephew, Richard R. Behringer, Facundo M. Fernandez, Chi-Heum Cho, Barbara Vanderhyden, Ronny Drapkin, Robert C. Bast, Kathy D. Miller, Adam R. Karpf, Jaeyeon Kim

PLOS GENETICS (2020)

添加到收藏夹

Article Oncology

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women

Aleksandra Gentry-Maharaj, Oleg Blyuss, Andy Ryan, Matthew Burnell, Chloe Karpinskyj, Richard Gunu, Jatinderpal K. Kalsi, Anne Dawnay, Ines P. Marino, Ranjit Manchanda, Karen Lu, Wei-Lei Yang, John F. Timms, Max Parmar, Steven J. Skates, Robert C. Bast, Ian J. Jacobs, Alexey Zaikin, Usha Menon

CANCERS (2020)

添加到收藏夹

Article Oncology

Biomarkers and Strategies for Early Detection of Ovarian Cancer

Robert C. Bast, Zhen Lu, Chae Young Han, Karen H. Lu, Karen S. Anderson, Charles W. Drescher, Steven J. Skates

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

添加到收藏夹

Article Oncology

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin

Dengxuan Fan, Hailing Yang, Weiqun Mao, Philip J. Rask, Lan Pang, Congjian Xu, Hariprasad Vankayalapat, Ahmed A. Ahmed, Robert C. Bast, Zhen Lu

Summary: The study reveals that ARN-3261 can enhance the efficacy of paclitaxel and carboplatin in treating ovarian cancer by increasing their ability to kill cancer cells and decreasing survivin levels. Further clinical evaluation of ARN-3261 is warranted based on these preclinical findings.

CANCERS (2021)

添加到收藏夹

Article Oncology

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer

Johannes F. Fahrmann, Ehsan Irajizad, Makoto Kobayashi, Jody Vykoukal, Jennifer B. Dennison, Eunice Murage, Ranran Wu, James P. Long, Kim-Anh Do, Joseph Celestino, Karen H. Lu, Zhen Lu, Robert C. Bast, Samir Hanash

Summary: The study identified a plasma polyamine signature associated with ovarian cancer that complemented CA125 in detecting early-stage ovarian cancer, providing potential markers for improving sensitivity in ovarian cancer detection. Mass spectrometry quantified four polyamines in plasma samples from ovarian cancer cases and controls, with a polyamine signature showing improved sensitivity and capturing cases missed by CA125 alone. This MYC-driven plasma polyamine signature offers promise for enhancing early ovarian cancer detection.

CANCERS (2021)

添加到收藏夹

Editorial Material Oncology

Circulating Cancer Biomarkers

Anna Lokshin, Robert C. Bast, Karin Rodland

CANCERS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells

Mara Artibani, Kenta Masuda, Zhiyuan Hu, Pascal C. Rauher, Garry Mallett, Nina Wietek, Matteo Morotti, Kay Chong, Mohammad KaramiNejadRanjbar, Christos E. Zois, Sunanda Dhar, Salma El-Sahhar, Leticia Campo, Sarah P. Blagden, Stephen Damato, Pubudu N. Pathiraja, Shibani Nicum, Fergus Gleeson, Alexandros Laios, Abdulkhaliq Alsaadi, Laura Santana Gonzalez, Takeshi Motohara, Ashwag Albukhari, Zhen Lu, Robert C. Bast, Adrian L. Harris, Christer S. Ejsing, Robin W. Klemm, Christopher Yau, Tatjana Sauka-Spengler, Ahmed Ashour Ahmed

Summary: In this study, researchers found that minimal residual disease (MRD) cells in ovarian cancer patients share important molecular signatures with tumor-initiating cells (TICs), while also exhibiting an adipocyte-like gene expression signature and undergoing epithelial-mesenchymal transition (EMT). Through a cell culture MRD model, it was discovered that MRD-mimic cells are dependent on fatty acid oxidation (FAO) for survival and resistance to cytotoxic agents. These findings suggest that EMT and FAO could be potential targets for eradicating MRD in ovarian cancer and support further testing of FAO inhibitors for MRD treatment.

JCI INSIGHT (2021)

添加到收藏夹

Article Oncology

Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

Chae Young Han, David A. Patten, Se Ik Kim, Jung Jin Lim, David W. Chan, Michelle K. Y. Siu, Youngjin Han, Euridice Carmona, Robin J. Parks, Cheol Lee, Li-Jun Di, Zhen Lu, Karen K. L. Chan, Ja-Lok Ku, Elizabeth A. Macdonald, Barbara C. Vanderhyden, Anne-Marie Mes-Masson, Hextan Y. S. Ngan, Annie N. Y. Cheung, Yong Sang Song, Robert C. Bast, Mary-Ellen Harper, Benjamin K. Tsang

Summary: This study highlights the functional interaction between HKII and activated P-p53 (Ser15) in the regulation of bioenergetics and chemosensitivity, emphasizing the increased nuclear HKII-P-p53 (Ser15) interaction as a potential prognostic biomarker in ovarian cancer.

CANCERS (2021)

添加到收藏夹

Review Oncology

DIRAS3: An Imprinted Tumor Suppressor Gene that Regulates RAS and PI3K-driven Cancer Growth, Motility, Autophagy, and Tumor Dormancy

Gamze Bildik, Xiaowen Liang, Margie N. Sutton, Robert C. Bast, Zhen Lu

Summary: DIRAS3 is an imprinted tumor suppressor gene that blocks RAS function, inhibits malignant transformation and cancer cell growth, and facilitates the survival of dormant cancer cells. Downregulation of DIRAS3 expression is associated with various cancers and can serve as a target for novel therapy after conventional treatment.

MOLECULAR CANCER THERAPEUTICS (2022)

添加到收藏夹

Article Oncology

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer

Kristin L. M. Boylan, Ashley Petersen, Timothy K. Starr, Xuan Pu, Melissa A. Geller, Robert C. Bast, Karen H. Lu, Ugo Cavallaro, Denise C. Connolly, Kevin M. Elias, Daniel W. Cramer, Tanja Pejovic, Amy P. N. Skubitz

Summary: This study aimed to develop a multiprotein classifier for detecting early stages of ovarian cancer by analyzing the levels of 92 cancer-related proteins in the blood. The combination of four proteins successfully detected over 90% of women with ovarian cancer and improved sensitivity and specificity compared to using CA125 alone. These findings suggest potential new biomarkers for early stage ovarian cancer detection.

CANCERS (2022)

添加到收藏夹

Article Oncology

IL-6 promotes drug resistance through formation of polyploid giant cancer cells and stromal fibroblast reprogramming

Na Niu, Jun Yao, Robert C. Bast, Anil K. Sood, Jinsong Liu

Summary: The research revealed that IL-6 plays a crucial role in the formation and transformation of PGCCs into CAFs, and blocking IL-6 can attenuate tumor growth and inhibit drug resistance.

ONCOGENESIS (2021)

添加到收藏夹

Article Chemistry, Multidisciplinary

Directed evolution of cyclic peptides for inhibition of autophagy

Joshua P. Gray, Md. Nasir Uddin, Rajan Chaudhari, Margie N. Sutton, Hailing Yang, Philip Rask, Hannah Locke, Brian J. Engel, Nefeli Batistatou, Jing Wang, Brian J. Grindel, Pratip Bhattacharya, Seth T. Gammon, Shuxing Zhang, David Piwnica-Worms, Joshua A. Kritzer, Zhen Lu, Robert C. Bast, Steven W. Millward

Summary: Autophagy induction has been found to play a crucial role in the development of treatment resistance and dormancy in various cancer types. Current autophagy inhibitors, such as chloroquine and hydroxychloroquine, face challenges of poor pharmacokinetics and high toxicity at therapeutic dosages. Through the use of Scanning Unnatural Protease Resistant (SUPR) mRNA display, macrocyclic peptides targeting the autophagy protein LC3 were developed, showing promising results in sensitizing platinum-resistant ovarian cancer cells to chemotherapy. These peptides disrupted protein-protein interactions and inhibited autophagic flux, leading to significant tumor growth inhibition in mouse models of metastatic ovarian cancer.

CHEMICAL SCIENCE (2021)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.